Inogen, Inc.

Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech

Inogen signed a definitive agreement to divest its U.S. oxygen rental business to Rotech Healthcare for estimated cash consideration of up to $25 million, expected to close in Q4 2026. The Rental Business generated $24.3 million of revenue in H1 2026, down 9.8% year-over-year; Inogen will present it as discontinued operations beginning with Q3 2026 results and expects the deal to raise revenue growth and adjusted operating income. Inogen also signed a long-term supply agreement with Rotech, and its board approved a $15 million buyback authorization increase (to $45 million total), contingent on the transaction closing.

•1mo ago

Inogen Announces Second Quarter 2026 Financial Results

Inogen reported Q2 2026 revenue of $95.1 million, up 3% year-over-year, driven by a 14.8% increase in international sales, while U.S. sales and rentals declined. Adjusted EBITDA turned positive at $2.4 million, leading the company to raise its full-year guidance to approximately $4.0 million, representing a 48% increase from 2025. The company generated $2.9 million in operating cash flow, ended the quarter with $106.8 million in cash and no debt, and repurchased $7.5 million of shares.

•2mo ago

Smartbird Nominates Tech Industry Veterans Elizabeth Mora and Dan Kasun for Election to Its Board of Directors

Smartbird announced the nomination of Elizabeth Mora and Dan Kasun for election to its board of directors at the upcoming annual stockholder meeting. Mora brings significant finance and governance experience, having served as CFO of Draper Laboratory and Harvard University, and currently holds board seats at Inogen, MKS Instruments, and Limoneira. Kasun contributes deep AI and cloud sales expertise from 18 years at Microsoft and 11 years at AWS, currently serving as SVP at Pegasystems, which CEO Nadia Carlsten noted will be an advantage for growth.

•2mo ago

Inogen Announces the Appointment of Andy Reding as Chief Operating Officer

Inogen appointed Andy Reding as its new Chief Operating Officer, a newly created position effective July 6, 2026, to strengthen its global commercial and operational execution. Reding brings over 30 years of experience, having served as Chief Commercial Officer at Viant Medical and VP/GM of Hillrom Respiratory Health. As an inducement, Reding received 130,000 restricted stock units, with one-third vesting annually over three years.

•4mo ago

Inogen Announces First Quarter 2026 Financial Results

Inogen reported Q1 revenue of $85.1 million, up 3.4% year-over-year, exceeding its internal outlook as international demand offset softer U.S. sales. The company reiterated its full-year 2026 revenue guidance of $366 million to $373 million and authorized a $30 million share repurchase program. Product highlights included the U.S. launch of Aurora CPAP masks and the Brazil launch of the Rove 6 portable oxygen concentrator, alongside a new U.S. reimbursement trial for Simeox 200.

•5mo ago